D.E. Shaw & Co
APGN

D.E. Shaw & Co’s Apexigen, Inc. Common Stock APGN Stock Holding History

D.E. Shaw & Co’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-173,965
Closed -$1.77M – 5716
2022
Q2 		$1.77M Hold
173,965
– – ﹤0.01% 3176
2022
Q1 		$1.75M Buy
173,965
+5,114
+3% +$51.3K ﹤0.01% 3428
2021
Q4 		$1.69M Buy
168,851
+106,317
+170% +$1.06M ﹤0.01% 3509
2021
Q3 		$622K Buy
+62,534
New +$618K ﹤0.01% 3949

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return